These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 24620801)

  • 1. Tiered approach revisited: introducing stage-appropriate or assay-appropriate scientific validation.
    Timmerman P
    Bioanalysis; 2014 Mar; 6(5):599-604. PubMed ID: 24620801
    [No Abstract]   [Full Text] [Related]  

  • 2. A tiered approach to address regulatory drug metabolite-related issues in drug development.
    Ma S; Chowdhury SK
    Bioanalysis; 2014 Mar; 6(5):587-90. PubMed ID: 24620798
    [No Abstract]   [Full Text] [Related]  

  • 3. Tiered approach: sense and sensibility.
    Abbott RW
    Bioanalysis; 2014 Mar; 6(5):611-6. PubMed ID: 24620803
    [No Abstract]   [Full Text] [Related]  

  • 4. Reflecting on a decade of metabolite screening and monitoring.
    Aubry AF; Christopher LJ; Wang J; Zhu M; Tirucherai G; Arnold ME
    Bioanalysis; 2014 Mar; 6(5):651-64. PubMed ID: 24620807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A reflection on fit-for-purpose metabolite investigation at different stages of drug development.
    Leclercq L
    Bioanalysis; 2014 Mar; 6(5):591-4. PubMed ID: 24620799
    [No Abstract]   [Full Text] [Related]  

  • 6. An industry perspective on tiered approach to the investigation of metabolites in drug development.
    Huskey SE; Li W; Mangold JB; Flarakos J
    Bioanalysis; 2014 Mar; 6(5):617-28. PubMed ID: 24620804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of commercial research-grade biomarker assays in drug development: is it time to create 'pharmaceutical-grade' kits?
    Bowsher RR; Nowatzke W; Sailstad JM; Khan MU
    Bioanalysis; 2012 Oct; 4(20):2427-30. PubMed ID: 23157350
    [No Abstract]   [Full Text] [Related]  

  • 8. Cardiac biomarkers: establishing reference ranges and standardization of assays across laboratories for clinical practice.
    Apple FS
    Clin Biochem; 2009 Mar; 42(4-5):295. PubMed ID: 19863925
    [No Abstract]   [Full Text] [Related]  

  • 9. Parallelism: considerations for the development, validation and implementation of PK and biomarker ligand-binding assays.
    Stevenson LF; Purushothama S
    Bioanalysis; 2014 Jan; 6(2):185-98. PubMed ID: 24423595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incurred sample reanalysis: dilemma in its applicability - should it be practiced for all bioanalytical assays involving single (parent or metabolite) or multiple analytes (parent/metabolite or parent with co-administered drugs)?
    Srinivas NR
    Biomed Chromatogr; 2011 Jun; 25(6):737-9. PubMed ID: 21465501
    [No Abstract]   [Full Text] [Related]  

  • 11. The proteomics bottleneck: strategies for preliminary validation of potential biomarkers and drug targets.
    Bodovitz S; Joos T
    Trends Biotechnol; 2004 Jan; 22(1):4-7. PubMed ID: 14690616
    [No Abstract]   [Full Text] [Related]  

  • 12. Recommendations on ISR in multi analyte assays, QA/bioanalytical consultants and GCP by Global CRO Council for Bioanalysis (GCC).
    Sangster T; Maltas J; Struwe P; Hillier J; Boterman M; Doig M; Breda M; Garofolo F; Caturla MC; Couerbe P; Schiebl C; Pattison C; Goodwin L; Segers R; Garofolo W; Folguera L; Zimmer D; Zimmerman T; Pawula M; Tang D; Cox C; Bigogno C; Schoutsen D; de Boer T; Green R; Houghton R; Sable R; Siethoff C; Harter T; Best S;
    Bioanalysis; 2012 Jul; 4(14):1723-30. PubMed ID: 22877218
    [No Abstract]   [Full Text] [Related]  

  • 13. Recommendations on the interpretation of the new European Medicines Agency Guideline on Bioanalytical Method Validation by Global CRO Council for Bioanalysis (GCC).
    Boterman M; Doig M; Breda M; Lowes S; Jersey J; Shoup R; Garofolo F; Dumont I; Martinez S; Needham S; Cruz Caturla M; Couerbe P; Guittard J; Maltas J; Lansing T; Bhatti M; Schiebl C; Struwe P; Sheldon C; Hayes R; Sangster T; Pattison C; Bouchard J; Goodwin L; Islam R; Segers R; Lin ZJ; Hillier J; Garofolo W; Zimmer D; Folguera L; Zimmermann T; Pawula M; Moussallie M; Teixeira Lde S; Rocha T; Tang D; Jardieu P; Truog J; Lin J; Lundberg R; Cox C; Breau A; Bigogno C; Schoutsen D; Dilger C; Bouhajib M; Levesque A; Gagnon-Carignan S; Nicholson R; Jenkins R; Lin MH; Karnik S; De Boer T; Houghton R; Green R; DeMaio W; Sable R; Smith K; Siethoff C; Cojocaru L; Allen M; Harter T; Fatmi S; Sayyarpour F; Malone M; Best S; Fang X
    Bioanalysis; 2012 Mar; 4(6):651-60. PubMed ID: 22452256
    [No Abstract]   [Full Text] [Related]  

  • 14. Tiered approach: from plan into practice.
    Timmerman P
    Bioanalysis; 2014 Mar; 6(5):585-6. PubMed ID: 24620797
    [No Abstract]   [Full Text] [Related]  

  • 15. The future of biomarkers.
    Aruoma OI; Bahorun T
    Toxicology; 2010 Dec; 278(2):161-4. PubMed ID: 20888386
    [No Abstract]   [Full Text] [Related]  

  • 16. [Nontraditional approaches to biomedical screening (multifactorial diseases). Communication I].
    Piruzian LA; Mikhaĭlovskiĭ EM
    Fiziol Cheloveka; 2007; 33(5):138-48. PubMed ID: 18038673
    [No Abstract]   [Full Text] [Related]  

  • 17. Proposal for a harmonized descriptive analyte nomenclature for quantitative large-molecule bioanalysis.
    Heinrich J; Staack RF; Stubenrauch KG; Papadimitriou A
    Bioanalysis; 2015 Dec; 7(24):3057-62. PubMed ID: 26505951
    [No Abstract]   [Full Text] [Related]  

  • 18. Giving consideration to scientific validation in Japanese drug application by Japan Bioanalysis Forum discussion group.
    Koseki N; Ashizawa H; Ishii T; Uchimura T; Ono K; Kuriyama S; Toda A; Soejima K; Nakai N; Nishimura N; Mayumi T; Yasuda Y; Yamakawa T; Niwa M
    Bioanalysis; 2017 Jul; 9(13):963-968. PubMed ID: 28708436
    [No Abstract]   [Full Text] [Related]  

  • 19. Best practices in a tiered approach to metabolite quantification: views and recommendations of the European Bioanalysis Forum.
    Timmerman P; Anders Kall M; Gordon B; Laakso S; Freisleben A; Hucker R
    Bioanalysis; 2010 Jul; 2(7):1185-94. PubMed ID: 21083233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prototypical process for creating evidentiary standards for biomarkers and diagnostics.
    Altar CA; Amakye D; Bounos D; Bloom J; Clack G; Dean R; Devanarayan V; Fu D; Furlong S; Hinman L; Girman C; Lathia C; Lesko L; Madani S; Mayne J; Meyer J; Raunig D; Sager P; Williams SA; Wong P; Zerba K
    Clin Pharmacol Ther; 2008 Feb; 83(2):368-71. PubMed ID: 18091762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.